Auke IjspeertAuke Ijspeert is a full professor at the EPFL, and head of the Biorobotics Laboratory (BioRob). He has a B.Sc./M.Sc. in physics from the EPFL (1995), and a PhD in artificial intelligence from the University of Edinburgh (1999). He carried out postdocs at IDSIA and EPFL, and at the University of Southern California (USC). He then became a research assistant professor at USC, and an external collaborator at ATR (Advanced Telecommunications Research institute) in Japan. In 2002, he came back to the EPFL as an SNF assistant professor. He was promoted to associate professor in October 2009 and to full professor in April 2016. His primary affiliation is with the Institute of Bioengineering, and secondary affiliation with the Institute of Mechanical Engineering. His research interests are at the intersection between robotics, computational neuroscience, nonlinear dynamical systems, and machine learning. He is interested in using numerical simulations and robots to get a better understanding of sensorimotor coordination in animals, and in using inspiration from biology to design novel types of robots and adaptive controllers. (see for instance Ijspeert et al Science 2007, Ijspeert Science 2014, and Nyakatura et al Nature 2019). He is also investigating how to assist people with limited mobility using exoskeletons and assistive furniture. He is regularly invited to give talks on these topics (e.g. TED talk given at TED Global Geneva, Dec 8 2015). With his colleagues, he has received paper awards at ICRA2002, CLAWAR2005, IEEE Humanoids 2007, IEEE ROMAN 2014, CLAWAR 2015, SAB2018, and CLAWAR 2019. He is an IEEE Fellow, member of the Board of Reviewing Editors of Science magazine, and associate editor for the IEEE Transactions on Medical Robotics and Bionics and for the International Journal of Humanoid Robotics. He has acted as an associate editor for the IEEE Transactions on Robotics (2009-2013) and for Soft Robotics (2018-2021). He was a guest editor for the Proceedings of IEEE, IEEE Transactions on Biomedical Engineering, Autonomous Robots, IEEE Robotics and Automation Magazine, and Biological Cybernetics. He has been the organizer of 7 international conferences (BioADIT2004, SAB2004, AMAM2005, BioADIT2006, LATSIS2006, SSRR2016, AMAM2019), and a program committee member of over 50 conferences.
Alexander MathisAlexander studied pure mathematics with a minor in logic and theory of science at the Ludwig Maximilians University in Munich. For his PhD also at LMU, he worked on optimal coding approaches to elucidate the properties of grid cells. As a postdoctoral fellow with Prof. Venkatesh N. Murthy at Harvard University and Prof. Matthias Bethge at Tuebingen AI, he decided to study olfactory behaviors such as odor-guided navigation, social behaviors and the cocktail party problem in mice. During this time, he increasingly got interested sensorimotor behaviors beyond olfaction and started working on proprioception, motor adaption, as well as computer vision tools for measuring animal behavior.
In his group, he is interested in elucidating how the brain gives rise to adaptive behavior. One of the major goals is to synthesize large datasets into computationally useful information. For those purposes, he develops algorithms and systems to analyze animal behavior (e.g. DeepLabCut), neural data, as well as creates experimentally testable computational models.
Shravan Tata RamalingasettyShravan Tata Ramalingasetty obtained his Mechatronics Bachelors in Engineering (B.E) degree from Manipal Institute of Technology, Manipal (2013). During his bachelors he worked on the thesis titled "Human Motion Analysis using Inertial Sensors" in collaboration with the Indian Institute of Technology (IISc), Bangalore. Later he continued working in IISc as Research Assistant with Computational Intelligence Laboratory(CInT) Lab on topics related to human bio-mechanics. Later he joined Technical University of Delft, Delft and graduated with Master of Science (M.Sc) degree in Bio-robotics (2016) after his competition of thesis titled "Cerebellum Inspired Computational Models for Robot Control". He then joined BioRob (2016) for his PhD funded by the Human Brain Project (HBP) to study the underlying mechanisms of locomotion in animals and humans.
Giuseppe SchiavoneTeaching & PhD Courses Neural interfaces NX-422 Neural interfaces (NI) are bioelectronic systems that interface the nervous system to digital technologies. This course presents their main building blocks (transducers, instrumentation & communication), reviews current and upcoming materials and technological solutions for implantable & wearable NI Soft Microsystems Processing and Devices MICRO-618 Amongst others, following topics will be covered during the course:- Soft Micros
Stéphanie LacourStéphanie P. Lacour holds the Bertarelli Foundation Chair in Neuroprosthetic Technology in the School of Engineering at EPFL and leads the Laboratory for Soft Bioelectronic Interfaces. She received her PhD in Electrical Engineering from INSA de Lyon, France, and completed postdoctoral research at Princeton University and the University of Cambridge. She is the recipient of the 2006 MIT TR35, a University Research Fellowship of the Royal Society, European Research Council ERC Starting and POC Grants, and a SNSF-ERC Consolidator Grant. She was elected a 2015 Young Global Leader by the World Economic Forum.
Mackenzie MathisCenter for NeuroprostheticsEPFL ELLIS Unit Faculty MemberCenter for Intelligent Systems
Mohamed BouriDr. Mohamed Bouri is a group leader of Rehabilitation and Assistive Robotics in LSRO and lecturer of Robotics and Industrial Robotics. He graduated in Electrical Engineering in 1992 and obtained his PhD degree in 1997 in Industrial Automation at INSA LYON, France. Since 1997, he is at EPFL and is mainly active in the field of robot control, automation and robot design for medical and industrial applications. He is the head of Rehabilitation and Assistive Robotics group since 2005 and has strong references with the development of robotic devices for lower limb rehabilitation : The MotionMaker and WalkTrainer commercialzed by the company Swortec. His ongoing research currently focuses on the development of exoskeletons and the associated control strategies. His main current projects are TWIICE, a lower limb exoskeleton for people with paraplegia, AUTONOMYO, a walk assistance exoskeleton for people with muscle weakness, and the HiBSO, a hip orthosis for elderly.
Solaiman Shokur2019 - now : Senior Scientist, Translational neuroengineering Laboratory, EPFL(Geneva)
Team leader: CHRONOS project, a multi-center European project that aims at developing the first chronically implanted prosthetic hand for transradial amputee patients with bidirectional communication capabilities. NCCR Robotics: Bi-directional control of supernumerary limbs.2014-2019: Research Coordinator, AASDAP (São Paulo, Brazil) Responsible for both the scientific production and the clinical protocol at the AASDAP neurorehabilitation laboratory.
2013-2014: Postdoctoral associate, Walk again project, Insituto Santos Dumond. (Natal, RN, Brazil)Head of the engineering team in charge of the system integration. 2010-2012: Visiting scientist, Nicolelis Lab (Duke University).
Development and validation of a virtual-reality based brain-machine interface for rhesus monkeys.
2007 – 2010: Teaching assistant, Laboratory of Robotics Systems (EPFL)
Jocelyne BlochTeaching & PhD PhD Students Camille Marie Mélodie Frayssinhes Past EPFL PhD Students as codirector Sabry Barlatey, Aasta Parin Gandhi
Eduardo Martin MoraudExpertise
The Moraud group develops closed-loop neuromodulation therapies for movement disorders, particularly Parkinson’s disease, with a specific emphasis on gait and balance impairments. The group integrates multimodal monitoring of motor and neural biomarkers to enable real-time decoding of dysfunctional states and their underlying neural dynamics, advancing a circuit-level understanding of locomotor control and informing the design of state-dependent adaptive therapies.
Mission
The group aims to transl
Quentin BarraudExpertise
Translational neuroscience · Neuromodulation · Spinal cord injury & Parkinson’s disease · Multi-omics (single-cell, spatial transcriptomics, 3D cleared-tissue imaging) · Preclinical platform management
Mission
To develop, coordinate, and supervise the preclinical activities of .NeuroRestore at EPFL, integrating innovative neuromodulation, gene therapy, and multi-omic strategies. To ensure regulatory compliance of all animal work, support scientific teams in experimental design, and build bridges b
Coralie BussoExpériences professionnelles Apprentie Laborantine 2001–2004 CMU Dpt. de physiologie cellulaire et métabolisme
RechercheCentrosomes promote timely mitotic entry in C. ele Dev Cell. 2007 Apr;12(4):531-41.Centrosomes promote timely mitotic entry in C. elegans embryos.Hachet V, Canard C, Gönczy P.SourceSwiss Institute for Experimental Cancer Research (ISREC), and School of Life Sciences, Swiss Federal Institute of Technology (EPFL), CH-1066 Lausanne, Switzerland.AbstractSeveral mitotic regulators, including
Ronan BoulicI come from Brittany, France, where I have completed my PhD degree in Computer Science in 1986 from the University of Rennes, France, at the INRIA-IRISA research institute. I also received the Habilitation degree from the University of Grenoble, France, in march 1995. I was hired in 1989 as First Assistant in the VRLAB, I became scientific collaborator, and senior researcher. I'm presently Senior Scientist (MER) and leader of the Immersive Interaction research Group (IIG). I'm co-author of around 150 research papers among which 43 appeared in international peer-reviewed journals. I have contributed to multiple SNF projects and EU projects. Please check iig.epfl.ch for more details.
Johan AuwerxJohan Auwerx is Professor at the École Polytechnique Fédérale in Lausanne, Switzerland, where he occupies the Nestle Chair in Energy Metabolism. Dr. Auwerx has been using molecular physiology and systems genetics to understand metabolism in health, aging and disease. Much of his work focused on understanding how diet, exercise and hormones control metabolism through changing the expression of genes by altering the activity of transcription factors and their associated cofactors. His work was instrumental for the development of agonists of nuclear receptors - a particular class of transcription factors - into drugs, which now are used to treat high blood lipid levels, fatty liver, and type 2 diabetes. Dr. Auwerx was amongst the first to recognize that transcriptional cofactors, which fine-tune the activity of transcription factors, act as energy sensors/effectors that influence metabolic homeostasis. His research validated these cofactors as novel targets to treat metabolic diseases, and spurred the clinical use of natural compounds, such as resveratrol, as modulators of these cofactor pathways.
Johan Auwerx was elected as a member of EMBO in 2003 and is the recipient of a dozen of international scientific prizes, including the Danone International Nutrition Award, the Oskar Minkowski Prize, and the Morgagni Gold Medal. His work is highly cited by his peers with a h-factor of over 100. He is an editorial board member of several journals, including Cell Metabolism, Molecular Systems Biology, The EMBO Journal, Journal of Cell Biology, Cell, and Science. Dr. Auwerx co-founded a handful of biotech companies, including Carex, PhytoDia, and most recently Mitobridge, and has served on several scientific advisory boards.
Dr. Auwerx received both his MD and PhD in Molecular Endocrinology at the Katholieke Universiteit in Leuven, Belgium. He was a post-doctoral research fellow in the Departments of Medicine and Genetics of the University of Washington in Seattle.
